Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker OPCH
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | R. Carter Pate Director | OPCH Option Care Health, Inc. | Sale | 400 | $31.65 | $12.7K Sale | Form 4 ↗ |
| Nov 10, 2026 | R. Carter Pate Director | OPCH Option Care Health, Inc. | Sale | 6,092 | $31.65 | $192.8K Sale | Form 4 ↗ |
| May 7, 2026 | Timothy P. Sullivan Director | OPCH Option Care Health, Inc. | Buy | 24,154 | $20.69 | $499.7K Buy | Form 4 ↗ |
| May 4, 2026 | Kraemer Harry M Jansen Jr Director | OPCH Option Care Health, Inc. | Buy | 36,610 | $21.41 | $783.8K Buy | Form 4 ↗ |
| May 4, 2026 | Meenal Sethna Chief Financial Officer | OPCH Option Care Health, Inc. | Buy | 16,225 | $20.16 | $327.1K Buy | Form 4 ↗ |
| May 4, 2026 | John Charles Rademacher Chief Executive Officer, Director | OPCH Option Care Health, Inc. | Buy | 12,500 | $21.18 | $264.8K Buy | Form 4 ↗ |
| Feb 27, 2026 | R. Carter Pate Director | OPCH Option Care Health, Inc. | Sale | 30,287 | $32.05 | $970.7K Sale | Form 4 ↗ |
| Feb 27, 2026 | Michael Bavaro Chief Human Resources Officer | OPCH Option Care Health, Inc. | Sale | 6,000 | $33.00 | $198.0K Sale | Form 4 ↗ |
| Nov 3, 2025 | Kraemer Harry M Jansen Jr Director | OPCH Option Care Health, Inc. | Buy | 38,000 | $25.98 | $987.2K Buy | Form 4 ↗ |
| Sep 9, 2025 | Norman L. Wright Director | OPCH Option Care Health, Inc. | Buy | 3,411 | $29.31 | $100.0K Buy | Form 4 ↗ |
| Aug 21, 2025 | Timothy P. Sullivan Director | OPCH Option Care Health, Inc. | Buy | 20,000 | $27.51 | $550.2K Buy | Form 4 ↗ |
| Aug 21, 2025 | David W. Golding Director | OPCH Option Care Health, Inc. | Buy | 1,000 | $27.63 | $27.6K Buy | Form 4 ↗ |
| Aug 20, 2025 | R. Carter Pate Director | OPCH Option Care Health, Inc. | Buy | 750 | $27.19 | $20.4K Buy | Form 4 ↗ |
| Aug 20, 2025 | Kraemer Harry M Jansen Jr Director | OPCH Option Care Health, Inc. | Buy | 36,000 | $27.15 | $977.4K Buy | Form 4 ↗ |
| Feb 28, 2025 | Michael Bavaro Chief Human Resources Officer | OPCH Option Care Health, Inc. | Sale | 30,996 | $33.26 | $1.0M Sale | Form 4 ↗ |
| Nov 8, 2024 | Kraemer Harry M Jansen Jr Director | OPCH Option Care Health, Inc. | Buy | 43,000 | $22.54 | $969.2K Buy | Form 4 ↗ |
16 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:05 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances